With a revenue increase of 63.92% in the third quarter 2026, year on year to cumulative value of $682 million, Tarsus Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,843,792, this is below the company average.
Within the Healthcare sector Employees of 54 other companies have achieved higher revenue per employee. While Tarsus Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 395 to 617. Tarsus Pharmaceuticals Inc has 370 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TARS Revenue per Employee	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Revenue Change	63.92 %	69.41 %	106.87 %	128.39 %	146.68 %
Sales per Employee (TTM) $	1,843,792	1,638,732	1,446,159	1,219,892	989,459
TARS's Total Ranking	# 617	# 395	# 32	# 66	#
Seq. Revenue Change	11.88 %	7.32 %	6.85 %	27.78 %	15.62 %

TARS Company Profile >> Back to TARS Efficiency Comparisons >> Compare TARS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 11
Healthcare Sector	# 55
Overall Market	# 617

Revenue per Employee Statistics
High	Average	Low
$ 1,638,732	$ 671,750	$ 47,011
(Jun 30 2026)		(Jun 30 2022)

Financial Statements
Tarsus Pharmaceuticals Inc 's Revenue MRQ	$ 195 Millions	Visit TARS's Income Statement
Tarsus Pharmaceuticals Inc 's Revenues TTM	$ 682 Millions	Visit TARS's aggregate revenue growth
What are TARS's Sales?		Visit TARS's Sales by Segment

Other Ratios
Tarsus Pharmaceuticals Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TARS's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TARS's Competitors
Revenue per Employee for TARS's Suppliers
Revenue per Employee for TARS's Customers

You may also want to know
TARS's Sales Growth Rates	TARS's Pe Price to earnings ratio	TARS's Receivables Turnover Ratio	TARS's Stock Quote
TARS's Net Income Growth Rates	TARS's Ps Price to Sales ratio	TARS's Sales per Employee	TARS's Asset Turnover Ratio
TARS's Net Margin	TARS's Pb Price to Book ratio	TARS's Financial Strength Ratios	TARS's Dividend Payout Ratio

Date modified: 2026-11-06T13:04:32+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2026	Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc	2,584,598.36	$ 945.963 Million	366
Aurinia Pharmaceuticals Inc	2,513,578.12	$ 321.738 Million	128
Sarepta Therapeutics Inc	2,342,920.96	$ 1,956.339 Million	835
Zevra Therapeutics Inc	2,304,065.57	$ 140.548 Million	61
Nurix Therapeutics Inc	2,214,309.15	$ 701.936 Million	317
Exelixis Inc	2,176,862.25	$ 2,496.861 Million	1,147
Incyte Corporation	2,113,485.94	$ 6,010.754 Million	2,844
Alnylam Pharmaceuticals Inc	2,005,296.80	$ 5,013.242 Million	2,500
Neurocrine Biosciences Inc	1,850,850.00	$ 3,701.700 Million	2,000
Tarsus Pharmaceuticals Inc	1,843,791.89	$ 682.203 Million	370
Gilead Sciences Inc	1,822,823.53	$ 30,988.000 Million	17,000
Mirum Pharmaceuticals Inc	1,803,166.67	$ 670.778 Million	372
Eli Lilly And Company	1,729,240.00	$ 86,462.000 Million	50,000
Alector Inc	1,684,165.05	$ 173.469 Million	103
Rigel Pharmaceuticals Inc	1,656,396.55	$ 288.213 Million	174
Jazz Pharmaceuticals Plc	1,632,569.55	$ 4,718.126 Million	2,890
Krystal Biotech Inc	1,593,305.08	$ 470.025 Million	295
Madrigal Pharmaceuticals Inc	1,560,590.16	$ 1,427.940 Million	915
Bristol myers Squibb Company	1,539,476.92	$ 50,033.000 Million	32,500
Acadia Pharmaceuticals Inc	1,506,642.86	$ 1,202.301 Million	798
Indivior Pharmaceuticals Inc	1,376,000.00	$ 1,376.000 Million	1,000
Biogen Inc	1,372,973.33	$ 10,297.300 Million	7,500
Supernus Pharmaceuticals inc	1,326,849.69	$ 865.106 Million	652
Corcept Therapeutics Inc	1,320,064.38	$ 963.647 Million	730
Travere Therapeutics Inc	1,309,927.57	$ 651.034 Million	497
Lantheus Holdings Inc	1,309,212.07	$ 1,561.890 Million	1,193
Ptc Therapeutics inc	1,166,048.44	$ 1,155.554 Million	991
Abbvie Inc	1,158,140.35	$ 66,014.000 Million	57,000
Biomarin Pharmaceutical Inc	1,134,780.19	$ 3,655.127 Million	3,221
Bridgebio Pharma Inc	1,126,984.51	$ 945.540 Million	839

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.